24 May 2013
Keywords: aveo, licenses, peptech, superhumanisation, technology, australian, drugmaker
Article | 08 October 2007
Australian drugmaker Peptech and the USA's AVEO Pharmaceuticals have entered into a non-exclusive research and commercialization agreement in which the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.